Workplace Flu Shots Programs for Corporates
As part of our health program, BizHealth provides on-site workplace flu vaccination services to employees across Australia and New Zealand. Across all major cities including Melbourne, Sydney, Brisbane, Perth, Adelaide, Canberra, Gold Coast and Auckland.
In Australia, there is an average of 85 deaths and over 4,000 hospitalisations recorded due to influenza illness each year.
At BizHealth, we provide on-site workplace flu vaccinations to employees as part of our health program.
Influenza (the flu) is an acute viral illness, costing Australian businesses millions of dollars every year in absenteeism and sick leave. Initially affecting around 20% of staff, influenza’s highly contagious nature means it spreads rapidly. It also takes an average of two weeks to recover from, creating extreme productivity losses in the workplace. Calling a professional corporate health provider like BizHealth can help you avoid this harm to your business.
Immunisation is the single most effective action for preventing the spread of the flu in your workplace, with scientific research showing that flu vaccination reduces the risk by 70-90% in healthy people. This translates to a 43% reduction in absenteeism or 74 fewer lost days per 100 employees. Book your workplace flu vaccination today!
Benefits of Promoting Onsite Workplace Flu Vaccination
Reduce the chances of Influenza (the flu) infection and cross-infection from co-workers.
Increase efficiency and keep employees safe in the workplace with workplace influenza vaccinations.
Workplace flu vaccinations help eliminate downtime and maximise productivity in the workplace.
The flu vaccination recommendations are updated regularly to keep up with new and changing strains of the influenza virus.
Commit to the well-being of your individual workers with corporate flu vaccination programs.
Flu vaccinations will help keep your workplace as safe and healthy as possible for all employees.
The risk of Flu complications is higher if you suffer from a chronic condition
Cardiac disease
Diabetes
Respiratory disease
Chronic kidney disease
Impaired immunity
A chronic neurological disorder
Down syndrome
Obesity
The influenza vaccination provided is designed to fight the strains of influenza circulating in the current year, and it’s not designed to fight the avian influenza ( also known as bird flu).
For more information, click here.
The Flu vaccine Contains the Flu virus
Flu vaccinations doesn’t contain any live virus, it is a mixture of protein and previous strains of influenza that are design to fight the dominant strain of influenza during each year recommended by the World Health Organisation (WHO). The Australian Influenza Vaccine Committee (AIVC) take in this recommendation and choose whether to implement or ignore these Vaccines to Australian residents.
Influenza Is Not that serious!
The flu virus is a highly contagious virus and it can be life threatening in some cases – it can cause an estimate of 1,500 deaths, 118,000 hospitalisations and 300,000 GP consultations annually in Australia. Although, many cases are deemed as non-threatening it is highly advised that an individual would seek medical advice in case of a more infectious virus strain.
The Flu vaccine Contains the Flu virus
Flu vaccinations doesn’t contain any live virus, it is a mixture of protein and previous strains of influenza that are design to fight the dominant strain of influenza during each year recommended by the World Health Organisation (WHO). The Australian Influenza Vaccine Committee (AIVC) take in this recommendation and choose whether to implement or ignore these Vaccines to Australian residents.
Influenza Is Not that serious!
The flu virus is a highly contagious virus and it can be life threatening in some cases – it can cause an estimate of 1,500 deaths, 118,000 hospitalisations and 300,000 GP consultations annually in Australia. Although, many cases are deemed as non-threatening it is highly advised that an individual would seek medical advice in case of a more infectious virus strain.
**Onsite staff flu vaccination services are available in 2022 – to reduce the spread of the flu before the winter peak season. Reduce the spread of infection in the workplace and minimise the cost of absenteeism with our programs.
BizHealth has an easy-to-use online booking system available with automatic email reminders. We also offer health seminars, which involve educating attendees about the importance of flu immunisation.
The Australian Influenza Vaccine Committee (AIVC) met to recommend the composition of the influenza virus vaccines for use within Australia in 2025. At this meeting, the expert committee reviewed and evaluated epidemiological, antigenic and genetic data of recent influenza isolates circulating in Australia and the southern hemisphere. Serological responses to the 2023-2024 vaccines, and the availability of candidate vaccines viruses and reagents, were also reviewed by the Committee.
AIVC Recommendation
The Committee recommended the following viruses for vaccines used in the 2025 southern hemisphere trivalent influenza vaccines in Australia:
an A/Victoria/4897/2022 (H1N1)pdm09-like virus;
an A/Croatia/10136RV/2023 (H3N2)-like virus; and
a B/Austria/1359417/2021 (B/Victoria lineage)-like virus;
an A/Wisconsin/67/2022 (H1N1)pdm09-like virus;
an A//District of Columbia/27/2023 (H3N2)-like virus; and
a B/Austria/1359417/2021 (B/Victoria lineage)-like virus;
The recommendation for the B/Yamagata lineage component of quadrivalent influenza vaccines remains unchanged from previous recommendations:
a B/Phuket/3073/2013 (B/Yamagata lineage)-like virus.
The recommendation for quadrivalent influenza vaccines for the 2025 southern hemisphere season includes the B/Yamagata lineage virus although in the absence of confirmed detection of this virus circulating, the World Health Organization’s (WHO) Influenza vaccine composition advisory committee recommended that continued inclusion of this antigen is no longer warranted. Consistent with previous recommendations, the WHO committee highlighted that every effort should be made to exclude this component from vaccines as soon as possible. The continued absence of confirmed detection of naturally occurring B/Yamagata lineage viruses after March 2020 is indicative of a very low risk of infection by B/Yamagata lineage viruses. The AIVC noted this position and supports the WHO committee’s views.
Candidate Vaccine Viruses (CVV) recommended may differ for egg- and cell-based vaccines. In some instances, the same virus is not ideal for both production systems. When this is the case, different viruses with similar properties are selected as the prototypes to help timely vaccine production. More information is available in the Frequently asked Questions – external site factsheet on the WHO’s website.
The AIVC recommendation for the composition of influenza vaccines for Australia in 2025 differs from the 2024 southern hemisphere and 2024/25 northern hemisphere recommendations. The southern hemisphere 2025 vaccine will contain one new strain for the Influenza A(H3N2) subtype virus component.
The recommendation made by AIVC aligns with the WHO recommendations (WHO recommendations for the 2025 Southern Hemisphere vaccines) – external site.
The TGA has accepted the recommendation of the AIVC.
The Australian Influenza Vaccine Committee (AIVC) met to recommend the composition of the influenza virus vaccines for Australia in 2024. At this meeting, the expert committee reviewed and evaluated epidemiology, antigenic and genetic data of recent influenza isolates circulating in Australia and the southern hemisphere. Serological responses to the 2022-2023 vaccines, and the availability of candidate vaccines viruses and reagents were also reviewed by the Committee.
an A/Victoria/4897/2022 (H1N1)pdm09-like virus;
an A/Thailand/8/2022 (H3N2)-like virus; and
a B/Austria/1359417/2021 (B/Victoria lineage)-like virus;
an A/Wisconsin/67/2022 (H1N1)pdm09-like virus;
an A/Massachusetts/18/2022 (H3N2)-like virus; and
a B/Austria/1359417/2021 (B/Victoria lineage)-like virus;
The recommendation for the B/Yamagata lineage component of quadrivalent influenza vaccines remains unchanged from previous recommendations:
a B/Phuket/3073/2013 (B/Yamagata lineage)-like virus.
The recommendation for quadrivalent influenza vaccines for 2024 southern hemisphere season includes the B Yamagata lineage virus although in the absence of confirmed detection of this virus circulating, WHO Influenza vaccine composition advisory committee recommended that continued inclusion of this antigen is no longer warranted.
Sodium chloride
Dibasic sodium phosphate
Monobasic sodium phosphate
Potassium chloride
Monobasic potassium phosphate
Calcium chloride dihydrate
Water for injections
For full information on the influenza strains for 2022 visit: Consumer Medicine Information (PDF)
https://www.tga.gov.au/aivc-recommendations-composition-influenza-vaccine-australia-2022
The Australian Influenza Vaccine Committee (AIVC) met on Wednesday 6th October 2021, to recommend the composition of the influenza virus vaccines for 2022. At this meeting, the expert committee reviewed and evaluated data related to epidemiology, antigenic and genetic characteristics of recent influenza isolates circulating in Australia and the Southern Hemisphere, serological responses to the 2020-2021 vaccines, and the availability of candidate vaccines viruses and reagents.
The committee recommended that the following viruses be included in quadrivalent influenza vaccines for the 2022 Southern Hemisphere influenza season:
a B/Austria/1359417/2021-like (B/Victoria lineage) virus; and
an A/Victoria/2570/2019 (H1N1)pdm09-like virus;
an A/Darwin/9/2021 (H3N2)-like virus;
a B/Phuket/3073/2013-like (B/Yamagata lineage) virus.
an A/Wisconsin/588/2019 (H1N1)pdm09-like virus;
an A/Darwin/6/2021 (H3N2)-like virus;
a B/Austria/1359417/2021 (B/Victoria lineage)-like virus; and
a B/Phuket/3073/2013 (B/Yamagata lineage)-like virus.
The composition of trivalent influenza vaccines is recommended to include the H1N1, H3N2 and the B Victoria lineage virus.
Sodium chloride
Dibasic sodium phosphate
Monobasic sodium phosphate
Potassium chloride
Monobasic potassium phosphate
Calcium chloride dihydrate
Water for injections
For full information on the influenza strains for 2023 visit: Consumer Medicine Information (PDF)
https://www.who.int/publications/m/item/recommended-composition-of-influenza-virus-vaccines-for-use-in-the-2023-southern-hemisphere-influenza-season
BizHealth provides workplace flu vaccinations to companies around Australia, including Melbourne, Sydney, Canberra, Perth, Adelaide and the Gold Coast. Here are some of the most frequently asked questions concerning these vaccinations.
Workplace flu shots help to protect your employees from becoming unwell with the influenza virus and transferring it to other employees, as well as their family and friends. Ultimately, these flu shots reduce the number of sick days taken by your employees, whilst ensuring that productivity isn’t jeopardised by high absenteeism rates.
Annual onsite flu vaccinations show your employees you care about their health and well-being and make it easy for them to receive their shots. Annual vaccination is important because the virus changes over time and previous vaccinations may no longer give the required protection.
Yes, the protection provided by the flu shot weakens over time which is why it’s important to time your corporate flu vaccinations just before the flu season commences. The ideal time to commence a vaccination program is late March to June but if you’ve missed this window, even later shots help to provide sufficient protection to outlast the flu season.
It’s important to prevent the spread of the flu throughout your workforce, so if anyone has the flu they need to stay at home. When they have a normal temperature for 24 hours without taking any medication and they feel well, they can safely return to work. The problem is that the flu spreads rapidly through an unvaccinated workforce and some people can become particularly unwell with this virus. Judiciously timed workplace flu vaccinations help to reduce the incidence of flu, keeping your employees and their families healthy.
With companies struggling to find enough staff to safely operate their businesses, earning a reputation as a proactive employer can give you a competitive edge. That’s because people are increasingly seeking out employers who offer a positive culture with great working conditions. So including a health and well-being program that promotes corporate flu vaccinations is a strategy that not only increases staff morale but also optimises health and safety in the workplace.
Workplace flu shots have been shown to prevent the flu in 50% to 60% of healthy adults under the age of 65 years. So whilst a vaccination reduces your risk of catching the flu it isn’t 100% effective. So, if you do catch the flu after having a vaccination it should lower your risk of becoming seriously ill and needing to be admitted to the hospital.
The flu vaccination doesn’t provide any protection against the coronavirus but it does protect against the influenza virus. Without adequate vaccinations, you could become ill with both COVID-19 and the flu, both of which can make you seriously ill. So it’s important that you get both your flu shot and the COVID vaccinations.
No. Onsite flu vaccinations don’t include any live viruses so you can’t catch the flu from one of these shots. Some people, however, can feel unwell after getting their flu vaccination. These side effects of the flu shot are usually mild and are due to your immune system responding to the vaccine and getting ready to fight off the virus.
Since the most protection against the flu occurs in the first 3 to 4 months after receiving the vaccination, the best time for workplace flu vaccinations is late March to June. However, it’s never too late to vaccinate so always check with BizHealth if you think you’ve missed the boat.
There are many benefits of onsite flu vaccinations, one of which is making access to these flu shots easy for your employees. That’s because many people are too busy to go to their GP or just put it off and end up forgetting about it. Workplace flu shots negate these excuses, particularly when their employer is encouraging them to get vaccinated. Other benefits include reduced sick leave because fewer employees become ill with the flu. Another is increased staff morale because employees appreciate that their employer cares about their health and well-being.
We’ll provide you with a booking coordinator who will provide you with posters and flyers to advertise the service and how employees can book their onsite flu vaccinations.
Most people are protected within 2 to 3 weeks following their vaccination with this immunity lasting for 3 to 4 months. Getting vaccinated during March to June provides immunity during the peak flu season.
Ask our experienced team for a quick quote now!